Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × Interferon alpha-2 × Clear all

NCT04379518 2026-01-13

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Phase 1/2 Terminated

4 enrolled 30 charts

Other hematologic neoplasm

Hematologic Neoplasms